CHARLESTON, SOUTH CAROLINA (PRWEB) NOVEMBER 09, 2015
Advanced Precision Medicine, Inc. (APM), a commercialization catalyst for molecular diagnostics, today announced that it has engaged the services of a specialty specimen management clinical research organization, Global Specimen Solutions, Inc. (GSS), to qualify innovative molecular diagnostics for inclusion in the Syner-G portfolio of molecular diagnostics. APM’s Syner-G portfolio of molecular diagnostics includes applications in oncology, autoimmunity, wellness, and pain management.
Read Advanced Precision Medicine, Inc.’s Press Release Here
Continue reading Advanced Precision Medicine, Inc. engages Global Specimen Solutions, Inc. to identify molecular diagnostics for commercial launch in U.S. CLIA labs
Bringing disruptive innovation into the marketplace is exciting for a new company. Day to day, innovation, process/product improvement and enhancement consume the start-up employee’s time, thoughts, and performance. Working in this culture is rewarding, fast-paced, and ever changing.
Continue reading Driving Disruptive Innovation- The Importance of Knowing Your Potential Customer
December 8 – 9, 2015
Clinical lab testing is becoming more complex. It is getting harder to implement new complex clinical protocols, especially ones requiring complicated bioassays for biologics. Additionally, an increase in rural global sites has added new hurdles for lab teams to overcome. Central lab outsourcing professionals must understand how the science and business of labs testing come together to clear the bottlenecks and keep trials on time and on budget. This is the only event dedicated to uncovering the secrets to effective central lab outsourcing and operations.
Learn More About the Event by Clicking Here or View the 2 Day Agenda
Continue reading 2nd Central Labs Partnership Forum
L. Scott Clark, Ph.D.
VP, Global Quality Assurance
Global Specimen Solutions
919.741.5008 x 115
High Growth Trajectory for the Specialist CRO Leads to New Offices in a Prime Location
August 4, 2015
Raleigh, North Carolina. – August 1, 2015, Global Specimen Solutions, Inc. (www.globalspecimensolutions.com), moved its offices to North Raleigh, expanding its footprint to allow for continued rapid growth of the company.
“Global Specimen Solutions, Inc. is growing at a rapid pace, providing innovative solutions that reduce the time, cost, and risk of specimen-based research. Our solutions have been in demand in the market, requiring us to accelerate our corporate growth plan. By locating in North Raleigh in the center of high growth biopharma companies, Global Specimen Solutions, Inc. is well positioned for its next phase of growth.” –Amelia Wall Warner, Founder and CEO
Global Specimen Solutions, Inc. located its offices in the Raleigh-Durham-Chapel Hill area to capitalize on the dynamic community of universities, informatics, and biopharma companies. Selecting a prime location was a key to assuring visibility and accessibility of the company to its client base.
“Global Specimen Solutions, Inc. continues to benefit from the rich scientific community in this area, drawing expertise for collaboration and partnerships as well as recruiting from a highly qualified local talent pool.”- Amelia Wall Warner, Founder and CEO
Continue reading Global Specimen Solutions, Inc. Expands, Moving Corporate Offices to North Raleigh
GSS is very excited to work with Volition Rx on this very promising technology by assisting Volition RX in their identification and collaborations with select medical universities and CLIA labs in the U.S.
Read Volition RX’s Press Release Here
Continue reading Global Specimen Solutions Selected by Volition RX to Support Initial U.S. Market Entry of its NuQ® Colorectal Cancer Tests
GSS Builds Informatics Expertise
July 14, 2015
Raleigh, North Carolina. – Global Specimen Solutions, Inc, an innovative specialty CRO focused on specimen management and informatics, announced today that Mark A Collins, PhD has joined the company as Chief Technology Officer.
Dr. Collins brings to Global Specimen Solutions, a unique combination of scientific, technical and business expertise, gained in a 20+ year career in start-ups, biotechnology and pharmaceutical companies, government research labs and as a co-founder of three companies.
Continue reading Global Specimen Solutions, Inc. Appoints Mark A. Collins Ph.D. as Chief Technology Officer